September 2026
The cns biomarkers market size was USD 8.81 billion in 2026, with leading cns biomarkers market players including F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Bio-Rad Laboratories, Quanterix Corporation.
September 2026
The neurological biomarkers market size reached USD 11.66 billion in 2026 and is projected to surpass around 34.02 billion by 2035, with a solid CAGR of 12.67%.
September 2026
The global CNS clinical trials market size was evaluated at USD 9.33 billion in 2026 and is predicted to hit around USD 18.49 billion by 2035, growing at a CAGR of 7.90%.
September 2026
The CNS drug discovery market was valued at USD 10.86 billion in 2026, with leading companies including Eli Lilly and Company, Roche, Novartis, Pfizer, AbbVie.
August 2026
The global cancer biomarkers market size was estimated at USD 15.58 billion in 2025 and is projected to hit around USD 47.14 billion by 2035 with a CAGR of 11.71%.
July 2026
The global digital biomarkers market size calculated at USD 5.04 billion in 2025 and is projected to hit around USD 36.98 billion by 2035 with a CAGR of 22.05%.
July 2026
The global biomarkers market size was valued at USD 94.24 billion in 2025 and is expected to hit around USD 355.72 billion by 2035 with a CAGR of 14.21%.
July 2026
The orphan disease biomarkers market expands with advancements in genomics, proteomics, and bioinformatics for rare conditions.
June 2026
The global circulating biomarkers market size is estimated to hit around USD 15.62 billion by 2035 increasing from USD 5.17 billion in 2025, with a CAGR of 11.69%.
June 2026
The global proteomic biomarkers market size is growing as advanced proteomics enhances disease diagnosis, prognosis, and personalized therapy.
June 2026
The global predictive biomarkers market size is valued at USD 28.88 billion in 2025 and is predicted to hit around USD 155.53 billion by 2035, at a CAGR of 18.34%.
May 2026
The parkinsons disease biomarkers market size reached USD 1.54 billion in 2026, with leading parkinsons disease biomarkers market companies including F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Thermo Fisher Scientific, Abbott Laboratories.
February 2026
The global veterinary biomarkers market size is estimated to hit around USD 4.13 billion by 2035 increasing from USD 1.24 billion in 2025, with a CAGR of 12.79%.
January 2026
The global personalized medicine biomarkers market size is projected to hit around USD 92.22 billion by 2035 from USD 22.04 billion in 2025 with a CAGR of 15.39%.
August 2025
The renal biomarkers market size was evaluated at USD 1.62 billion in 2024 and is projected to attain around USD 3.57 billion by 2034, with a solid CAGR of 8.22%.
August 2025
The global cardiac biomarkers market size reached USD 21.20 billion in 2024 and is projected to surpass around USD 82.99 billion by 2034, with a remarkable CAGR of 14.62%.
July 2025
The global in-vitro inflammatory bowel disease diagnostics market size was valued at USD 1.74 billion in 2024 and is expected to hit around USD 3.02 billion by 2034, at a CAGR of 5.64%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com